Medicine storage device and intelligent reminding method

By integrating temperature monitoring, alarm and wireless communication modules into the drug storage device, and combining weight sensors and infrared sensors, real-time monitoring and intelligent reminders of the drug storage environment are achieved, solving the problems of abnormal temperature and medication reminders, and improving the intelligence and safety of drug management.

CN120740249APending Publication Date: 2025-10-03SHANGHAI BOOHEE INFORMATION TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511050727.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-07-29
Publication Date
2025-10-03

AI Technical Summary

Technical Problem

Existing drug storage devices lack real-time temperature monitoring and alarm functions, which may cause the drug to become ineffective when the temperature is abnormal. In addition, the medication reminder method is single and users are prone to ignore it, making it difficult to meet the management needs of special drugs.

Method used

A drug storage device is designed with a built-in temperature monitoring module, control module, alarm module and wireless communication module. It monitors the temperature in real time and issues an alarm when an abnormality occurs. It combines a weight sensor and an infrared sensor to determine the drug access status, provides intelligent reminders through a mobile terminal, and supports fingerprint unlocking and drug information recognition to improve security.

Benefits of technology

It realizes real-time monitoring and intelligent reminders of the drug storage environment, reduces misjudgments, improves the accuracy and safety of drug management, ensures drug effectiveness, reduces the rate of missed use, and improves medication compliance and convenience of use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120740249A_ABST
    Figure CN120740249A_ABST
Patent Text Reader

Abstract

The invention provides a medicine storage device and an intelligent reminding method, and relates to the technical field of medicine management.The medicine storage device is characterized in that a medicine placement area is arranged in a storage container and used for storing target medicine; the temperature monitoring module is used for acquiring temperature data of the medicine placing area in real time; the control module is used for acquiring the temperature data and judging whether the temperature data is abnormal or not; when it is determined that the temperature data is larger than or equal to a preset failure temperature critical value, it is determined that the temperature data is abnormal, the control module controls the alarm module to give out a first alarm, and temperature abnormal information is sent to the mobile terminal through the wireless communication module; and when the temperature data is not abnormal and the target medicine is not taken within the set time, the control module controls the alarm module to give out a second alarm, and medicine taking reminding information is sent to the mobile terminal through the wireless communication module. By implementing the technical scheme of the application, the effect of improving the intelligent level of medication management is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of drug management, and in particular to a drug storage device and an intelligent reminder method. Background Art

[0002] With the continuous advancement of medical technology, the use of various medications is becoming increasingly widespread. For some medications that require refrigeration, their storage conditions are directly related to their effectiveness and safety. Proper medication storage not only ensures medication quality and extends its shelf life, but also reduces the health risks associated with medication deterioration. Consequently, people's requirements for medication storage environments are increasing. Conventional refrigerators or freezers are often used to store medications that require refrigeration. These lack real-time temperature monitoring and alarm functions, preventing users from promptly determining whether the medication storage environment meets standards. If the refrigerator malfunctions or the temperature becomes abnormal, the medication may become ineffective without their knowledge. Regarding medication reminders, some products only provide simple timed alarms that fail to correlate with the medication storage environment. These reminder methods are often limited and can be easily overlooked by users. These solutions suffer from issues such as delayed temperature monitoring and unintelligent reminder functions, resulting in low efficiency and quality, making them difficult to meet user management needs for certain specialized medications. Summary of the Invention

[0003] In order to solve the above technical problems, the present application provides a drug storage device and an intelligent reminder method.

[0004] In the first aspect, the present application provides a drug storage device, comprising: a storage container, in which a drug placement area is provided for storing a target drug; a temperature monitoring module, fixed to the inner wall of the storage container, for obtaining temperature data of the drug placement area in real time; a control module, electrically connected to the temperature monitoring module, for obtaining temperature data and determining whether the temperature data is abnormal; an alarm module, electrically connected to the control module, for receiving an alarm instruction sent by the control module and issuing a first alarm when the control module determines that the temperature data is abnormal; a wireless communication module, electrically connected to the control module, for sending temperature abnormality information to a mobile terminal; wherein the control module compares the temperature data with a preset failure temperature critical value, and when it is determined that the temperature data is greater than or equal to the preset failure temperature critical value, determines that the temperature data is abnormal, and controls the alarm module to issue a first alarm; the control module is also used to control the alarm module to issue a second alarm when there is no abnormality in the temperature data and the target drug is not taken within the set time, and send a medication reminder message to the mobile terminal through the wireless communication module.

[0005] By adopting the above technical solution, the drug placement area set in the storage container can be used to store the target drug, the temperature monitoring module can obtain the temperature data of the drug placement area in real time, and the control module can determine whether the temperature data is abnormal. When the temperature data is greater than or equal to the preset failure temperature critical value, the control alarm module will issue a first alarm and send temperature abnormality information to the mobile terminal through the wireless communication module to avoid the drug from failing due to temperature abnormality; when the temperature data is normal but the target drug is not taken within the set time, a second alarm will be issued and a medication reminder message will be sent to the mobile terminal to remind the user to take the medicine on time, thereby realizing the purpose of intelligent medication reminder and achieving the effect of improving the intelligence level of medication management.

[0006] Optionally, the drug storage device also includes: a weight sensor, electrically connected to the control module, arranged at the bottom of the drug placement area, for monitoring the weight of the target drug in real time; an infrared counter-radiation sensor, electrically connected to the control module, arranged on the inner side of the access port of the drug placement area, for detecting whether there is an occlusion signal of an object passing through the access port; wherein the control module determines the access status of the target drug in the following manner: when the infrared counter-radiation sensor detects an occlusion signal and the weight sensor detects a decrease in the weight value, it is comprehensively judged that the target drug has been taken.

[0007] By adopting this technical solution, a weight sensor monitors the target medication's weight in real time, while an infrared sensor detects occlusion signals from objects passing through the access port. The control module uses these combined detection results to determine the target medication's access status, accurately determining whether the target medication has been taken. This multi-sensor fusion approach allows for more precise determination of medication access, ensuring that a determination is made only when the medication has actually been taken, reducing the possibility of misjudgment and improving the accuracy of medication management.

[0008] Optionally, the control module is also used to: determine the remaining amount of the target drug based on the real-time detection value of the weight sensor; calculate the remaining number of medications based on the remaining amount and the preset single medication dose; when the remaining number of medications is lower than the preset number threshold, send a reminder message for replenishing the drug to the mobile terminal through the wireless communication module.

[0009] By adopting the above technical solution, the remaining amount of the target drug can be determined based on the real-time detection value of the weight sensor, and the remaining number of medications can be calculated in combination with the preset single dosage. When the remaining number of medications is lower than the preset threshold, a reminder message for replenishing medications is sent to the mobile terminal, thereby achieving the purpose of timely reminding users to replenish medications and avoiding health effects due to insufficient medications.

[0010] Optionally, the control module is also used to: record the time of each medication, the single medication dosage, the remaining number of medications and the medication collection temperature, and generate medication record information, wherein the medication time represents the time corresponding to when the control module determines that the target drug has been taken, and the medication collection temperature is used to represent the temperature data of the drug placement area corresponding to the medication time; upload the medication record information to the remote server so that the remote server can generate the corresponding drug management electronic file.

[0011] By adopting the above technical solution, the medication time, single medication dosage, remaining medication times and medication collection temperature are recorded and medication record information is generated, which can facilitate the understanding of medication usage. The medication record information is uploaded to the remote server to generate an electronic medication management file, which can achieve long-term tracking and management of medication usage and provide users with more scientific medication guidance.

[0012] Optionally, the drug storage device also includes: a fingerprint acquisition module, which is arranged on the outer cover surface of the drug storage device and is electrically connected to the control module; and an electric lock, which is controlled by the control module; wherein, when the fingerprint acquisition module recognizes a pre-stored fingerprint, the control module drives the electric lock to unlock to allow the drug storage device to be opened.

[0013] By adopting the above technical solution, fingerprint unlocking of the drug storage device can be achieved, thereby improving the security of the drug storage device, preventing unauthorized personnel or children from accidentally opening the device, and ensuring the safe storage of target drugs.

[0014] Optionally, the drug storage device also includes: an identification module, electrically connected to the control module, for scanning the barcode or QR code or RFID tag on the target drug package when the target drug is placed in the drug placement area or taken out from the drug placement area within a preset time after the electric lock is unlocked, so as to obtain drug information and transmit it to the control module, wherein the drug information includes the type information and expiration date information of the target drug; when the control module determines that the type information of the target drug does not match the currently unlocked user or determines that the target drug has expired, the control module controls the alarm module to generate a third alarm and sends risk reminder information to the mobile terminal through the wireless communication module.

[0015] By adopting the above technical solution, an identification module is added to scan the barcode, QR code or RFID tag on the target drug packaging to obtain the drug type and expiration date information. The control module combines the health record associated with the user's fingerprint and the system time to determine whether the drug type matches the user and whether the drug is expired. When a mismatch or expiration occurs, the alarm module is controlled to issue a third alarm and send a risk reminder message to the mobile terminal, thereby improving the safety of drug use and preventing users from accidentally taking mismatched or expired drugs.

[0016] Optionally, the control module determines that the type information of the target drug does not match the currently unlocked user by: retrieving the pre-stored user health record associated with the fingerprint of the currently unlocked user; when the type information of the target drug is different from the drug type in the pre-stored user health record, it is determined that the type information of the target drug does not match the currently unlocked user; the control module determines that the target drug is expired by: by comparing the identified expiration date information with the current system time; when the time corresponding to the expiration date information is earlier than the current system time, it is determined that the target drug is expired.

[0017] By adopting the above technical solution, it is possible to accurately determine whether the target drug type information matches the currently unlocked user and whether the target drug is expired. When a mismatch or expiration occurs, the alarm module can be controlled to issue a third alarm and send risk reminder information to the mobile terminal to prevent users from mistakenly taking the wrong drugs or using expired drugs, thereby ensuring medication safety.

[0018] Optionally, the drug storage device also includes: a lithium battery for powering the temperature monitoring module, the control module, the alarm module and the wireless communication module; a low-battery detection unit electrically connected to the lithium battery and the control module, for detecting the battery level of the lithium battery and transmitting it to the control module. When the control module determines that the battery level of the lithium battery is lower than a preset battery threshold, it sends a charging reminder message to the mobile terminal through the wireless communication module.

[0019] By adopting the above technical solution, the lithium battery powers the temperature monitoring module, control module, alarm module and wireless communication module to ensure the normal operation of the device; the low-battery detection unit detects the battery level of the lithium battery. When the battery level is lower than the preset battery threshold, the control module sends a charging reminder message to the mobile terminal through the wireless communication module to avoid affecting the device function due to insufficient battery.

[0020] Optionally, the alarm module includes: an audible and visual alarm component integrated in the storage container shell, the audible and visual alarm component including an LED indicator light and a buzzer; when the temperature data is greater than or equal to the preset failure temperature critical value and less than the preset dangerous temperature threshold, a first-level alarm is triggered; when the temperature data is greater than or equal to the preset dangerous temperature threshold, a second-level alarm is triggered, wherein the first alarm includes a first-level alarm and a second-level alarm.

[0021] By adopting the above technical solution, the sound and light alarm component is integrated into the storage container shell. When the temperature is abnormal, the alarm can be sounded through the LED indicator and buzzer, which can remind the user intuitively and promptly. According to the comparison of temperature data with the preset failure temperature critical value and the preset dangerous temperature threshold, different levels of alarms are triggered, allowing users to understand the severity of the temperature abnormality more clearly and take timely measures to ensure the effectiveness and safety of the drug.

[0022] Optionally, the drug storage device further includes: a display module electrically connected to the control module, the display module being used to display temperature data of the target drug and a status of whether the target drug has been taken.

[0023] By adopting the above technical solution, the temperature data of the target drug can be displayed in real time, allowing users to timely understand the temperature of the drug storage environment. It can also display whether the target drug has been taken, making it convenient for users to clearly understand the drug usage situation.

[0024] Optionally, the drug storage device further includes: a voice broadcast module electrically connected to the control module. When the target drug is taken, the display module is also used to display the medication standards corresponding to the target drug, and the voice broadcast module is used to broadcast the medication standards.

[0025] By adopting the above technical solution, when the target drug is taken, the display module displays the medication standards, and the voice broadcast module broadcasts the medication standards, which can help users intuitively obtain the medication standards and facilitate users to use the medication correctly.

[0026] Optionally, the drug storage device also includes: a cooling plate, which is attached to the inner wall of the storage container and is used to reduce the temperature of the drug placement area; a power adjustment module, which is electrically connected to the control module and the cooling plate; wherein the control module dynamically adjusts the power of the cooling plate according to the difference between the temperature data obtained in real time by the temperature monitoring module and the preset failure temperature critical value: when the temperature data is greater than or equal to the preset failure temperature critical value, the power of the cooling plate is gradually increased until the temperature of the drug placement area is lower than the preset failure temperature critical value.

[0027] By adopting the above technical solution, the cooling plate can lower the temperature of the drug placement area. The power adjustment module cooperates with the control module to dynamically adjust the cooling plate power according to the difference between the temperature data and the preset failure temperature critical value. When the temperature data is greater than or equal to the preset failure temperature critical value, the cooling plate power is gradually increased until the temperature of the drug placement area is less than the preset failure temperature critical value. The temperature of the drug placement area can be kept within an appropriate range to ensure the effectiveness and safety of the target drug.

[0028] In the second aspect of the present application, an intelligent reminder method is also provided, which is applied to any of the aforementioned drug storage devices, including: a temperature monitoring module monitors the temperature data of the drug placement area in real time, wherein the drug placement area is used to store the target drug; a control module receives the temperature data, and determines whether the temperature data is abnormal by comparing the temperature data with a preset failure temperature critical value; when it is determined that the temperature data is greater than or equal to the preset failure temperature critical value, when it is determined that the temperature data is abnormal, the control module controls the alarm module to issue a first alarm, and sends the temperature abnormality information to the mobile terminal through the wireless communication module; and, when there is no abnormality in the temperature data and when the target drug is not taken within the set time, the control module controls the alarm module to issue a second alarm, and sends medication reminder information to the mobile terminal through the wireless communication module.

[0029] By adopting the above technical solution, the temperature data of the drug placement area can be monitored in real time, temperature anomalies can be detected in time, and alarms and notifications can be issued to mobile terminals to prevent drugs from becoming ineffective due to temperature anomalies. It can also remind users to take medication if the target medication is not taken on time, thereby improving the timeliness and standardization of medication.

[0030] In a third aspect of the present application, an electronic device is provided, comprising a memory and a processor, wherein a computer program is stored in the memory, and the processor implements any one of the above method steps when executing the program.

[0031] In a fourth aspect of the present application, a computer-readable storage medium is further provided. The computer-readable storage medium stores instructions. When the instructions are executed, any one of the above method steps is performed.

[0032] In summary, one or more technical solutions provided in this application have at least the following technical effects or advantages: 1. The drug placement area set in the storage container can be used to store target drugs. The temperature monitoring module can obtain the temperature data of the drug placement area in real time. The control module can determine whether the temperature data is abnormal. When the temperature data is greater than or equal to the preset failure temperature critical value, a first alarm is issued and a temperature abnormality information is sent to the mobile terminal to prevent the drug from failing due to temperature abnormality. When the temperature data is normal but the target drug is not taken within the set time, a second alarm is issued and a medication reminder message is sent to the mobile terminal to remind the user to take the medicine on time, thereby realizing the purpose of intelligent medication reminder and achieving the effect of improving the intelligent level of medication management. 2. Through multi-sensor fusion detection, it can more accurately determine whether the target drug has been taken, ensuring that judgments are made only when the drug has actually been taken, reducing the possibility of misjudgment and improving the accuracy of drug management; 3. The remaining amount of the target drug can be determined based on the real-time detection value of the weight sensor, and the remaining number of medications can be calculated based on the preset single dosage. When the remaining number of medications is lower than the preset threshold, a reminder message for replenishing medications can be sent to the mobile terminal to achieve the purpose of timely reminding users to replenish medications. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 This is a structural block diagram of a drug storage device provided in an embodiment of the present application; Figure 2 This is a flow chart of an intelligent reminder method provided by an embodiment of the present application; Figure 3 This is a schematic diagram of an application scenario provided by an embodiment of the present application; Figure 4 This is a structural diagram of an electronic device provided in an embodiment of the present application.

[0034] Description of reference numerals: 400 - electronic device; 401 - processor; 402 - communication bus; 403 - user interface; 404 - network interface; 405 - memory. DETAILED DESCRIPTION

[0035] In order to enable those skilled in the art to better understand the technical solutions in this specification, the technical solutions in the embodiments of this specification will be clearly and completely described below in conjunction with the drawings in the embodiments of this specification. Obviously, the described embodiments are only part of the embodiments of this application, not all of the embodiments.

[0036] In the description of the embodiments of this application, words such as "for example" or "for instance" are used to indicate examples, illustrations, or explanations. Any embodiment or design described as "for example" or "for instance" in the embodiments of this application should not be construed as being preferred or advantageous over other embodiments or designs. Rather, the use of words such as "for example" or "for instance" is intended to present the relevant concepts in a concrete manner.

[0037] In the description of the embodiments of the present application, the term "plurality" means two or more. In addition, the terms "first" and "second" are used for descriptive purposes only and are not to be understood as indicating or implying relative importance or implicitly indicating the indicated technical features. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of such features. The terms "include," "comprise," "have" and their variations all mean "including but not limited to," unless otherwise specifically emphasized.

[0038] This application provides a drug storage device, referring to Figure 1 , Figure 1This is a structural block diagram of a drug storage device provided by an embodiment of the present application, the device including: a storage container, in which a drug placement area is provided for storing a target drug; a temperature monitoring module, fixed to the inner wall of the storage container, for obtaining temperature data of the drug placement area in real time; a control module, electrically connected to the temperature monitoring module, for obtaining temperature data and determining whether the temperature data is abnormal; an alarm module, electrically connected to the control module, for receiving an alarm instruction sent by the control module and issuing a first alarm when the control module determines that the temperature data is abnormal; a wireless communication module, electrically connected to the control module, for sending temperature abnormality information to a mobile terminal; wherein the control module compares the temperature data with a preset failure temperature critical value, and when it is determined that the temperature data is greater than or equal to the preset failure temperature critical value, determines that the temperature data is abnormal, and controls the alarm module to issue a first alarm; the control module is also used to control the alarm module to issue a second alarm when there is no abnormality in the temperature data and the target drug is not taken within the set time, and to send a medication reminder message to the mobile terminal through the wireless communication module.

[0039] In the above embodiment, the drug placement area set in the storage container can be used to store the target drug, the temperature monitoring module can obtain the temperature data of the drug placement area in real time, and the control module can determine whether the temperature data is abnormal. When the temperature data is greater than or equal to the preset failure temperature critical value, the control alarm module issues a first alarm and sends temperature abnormality information to the mobile terminal through the wireless communication module to avoid the drug from failing due to temperature abnormality; when the temperature data is normal but the target drug is not taken within the set time, a second alarm is issued and a medication reminder message is sent to the mobile terminal to remind the user to take the medicine on time, thereby realizing the purpose of intelligent medication reminder and achieving the effect of improving the intelligence level of medication management.

[0040] The intelligent drug storage device of this embodiment achieves real-time monitoring of the drug storage environment and intelligent reminders through the collaborative operation of multiple modules. Specifically, the temperature monitoring module, mounted on the inner wall of the storage container, acquires real-time temperature data from the drug storage area. This data serves as the basis for determining whether the drug storage environment meets standards. The control module, as the core processing unit, receives temperature data from the temperature monitoring module and compares the actual temperature data with a preset failure temperature threshold to determine whether the temperature is abnormal. If the temperature data is greater than or equal to the preset failure temperature threshold, it indicates a temperature abnormality, triggering the alarm module to issue a first alarm. If the temperature is normal but the target drug is not taken within a set time, the alarm module triggers a second alarm. The alarm module issues two types of alarms based on the control module's instructions: the first alarm notifies the user of a temperature abnormality, and the second alarm reminds the user to take medication on time. The wireless communication module (e.g., Bluetooth / Wi-Fi) transmits temperature abnormality information and medication reminders to the user's mobile device. The mobile terminal app alerts the user through various methods, such as pop-up windows, vibration, and voice notifications, allowing the user to obtain timely information even when not near the drug storage device. In actual applications, in terms of medication reminders, users can customize the medication time and dosage on the APP. The APP will notify the user through the mobile phone before the set time. If the user does not respond in time, the drug storage device will issue a reminder again. In the related art, ordinary refrigerators or freezers lack real-time monitoring and alarm functions. When the temperature is abnormal, the user cannot know in time, which may cause the drug to become ineffective. The drug storage device of this embodiment obtains temperature data in real time through the temperature monitoring module, and the control module determines in real time whether the temperature is abnormal, which solves the problems of temperature monitoring lag and untimely transmission of abnormal information in the related art; in addition, the medication reminder in the related art is only a simple timing and has nothing to do with the storage environment. The reminder method is single and users can easily ignore it. The control module combines temperature data and drug access time to achieve intelligent reminders. When the drug is not taken within the set time, a medication reminder alarm is issued, and the reminder information is sent to the mobile terminal through the wireless communication module, which improves the effectiveness and intelligence level of the reminder. Through this embodiment, real-time temperature monitoring and abnormality alarms (local alarms + mobile terminal notifications) ensure that users address temperature anomalies promptly, preventing medication from becoming ineffective due to environmental conditions exceeding standards and reducing health risks. Medication reminders are linked to the storage environment status and pushed via mobile terminals, increasing the relevance of reminders and user attention, helping to improve medication compliance. The integration of temperature monitoring, abnormality warnings, and medication reminders upgrades medication storage from "passive storage" to "active management," meeting the stringent requirements of specialty medications for storage environments and medication regulations, and improving overall management efficiency and quality. This embodiment's dual trigger mechanism (temperature anomaly alarm + medication timeout reminder) reduces the missed use rate of specialty medications by 60%-70%, making it particularly suitable for time-sensitive medications such as insulin and vaccines.The drug storage device of this embodiment sends important information to a mobile terminal via a wireless communication module, allowing users to understand drug storage status and medication reminders anytime and anywhere, thereby improving user convenience and satisfaction. The drug storage device of this application may be a medicine box or medicine cabinet or other device for storing drugs. Optionally, the above-mentioned storage container may include multiple drug placement areas, or the above-mentioned drug placement area may include multiple independent partitions, each partition being provided with an independent temperature sensor for separately monitoring the storage temperature of the drugs in the corresponding partitions.

[0041] In an optional embodiment, the drug storage device also includes: a weight sensor, electrically connected to the control module, arranged at the bottom of the drug placement area, for monitoring the weight of the target drug in real time; an infrared counter-radiation sensor, electrically connected to the control module, arranged on the inner side of the access port of the drug placement area, for detecting whether there is an occlusion signal of an object passing through the access port; wherein the control module determines the access status of the target drug in the following manner: when the infrared counter-radiation sensor detects an occlusion signal and the weight sensor detects a decrease in the weight value, it is comprehensively judged that the target drug has been taken.

[0042] In the above embodiment, a weight sensor monitors the target medication's weight in real time, while an infrared sensor detects occlusion signals from objects passing through the access port. The control module uses these combined detection results to determine the target medication's access status, accurately determining whether the target medication has been taken. This multi-sensor fusion approach allows for more precise determination of medication access, ensuring that a determination is made only when the medication has actually been taken, reducing the possibility of misjudgments and improving medication management accuracy.

[0043] A weight sensor, located at the bottom of the medication storage area, monitors the weight of the target medication in real time. When medication is removed, the weight sensor detects a decrease in weight. An infrared sensor, located inside the medication access opening, emits and receives infrared beams to detect whether an object (such as a hand or a medicine bottle) passes through the access opening. When the infrared sensor detects an occlusion signal (i.e., an interrupted beam), it indicates that medication may have been removed. The control module combines the signals from the weight and infrared sensors to determine medication removal status. Only when the infrared sensor detects an occlusion signal and the weight sensor detects a decrease in weight is the medication considered removed. This dual detection mechanism effectively prevents false positives. For example, if the user opens the storage device but does not remove medication (infrared trigger only) or if external vibration causes weight fluctuations (weight change only), false positives will be avoided, reducing false alarms. In this embodiment, the control module accurately determines whether medication has been removed and only issues a medication reminder when the medication has not been removed and the set time has expired. This avoids unnecessary and repeated reminders and improves reminder effectiveness. Users can more accurately understand medication removal status and avoid the frustration caused by false positives. At the same time, accurate medication reminders can also help users better manage drug use and improve the overall usage experience.

[0044] In an optional embodiment, the control module is also used to: determine the remaining amount of the target drug based on the real-time detection value of the weight sensor; calculate the remaining number of medications based on the remaining amount and the preset single medication dose; when the remaining number of medications is lower than the preset number threshold, send a reminder message for replenishing the drug to the mobile terminal through the wireless communication module.

[0045] In the above embodiment, the remaining amount of the target drug can be determined based on the real-time detection value of the weight sensor, and the remaining number of medications can be calculated in combination with the preset single dosage. When the remaining number of medications is lower than the preset threshold, a reminder message for replenishing medications is sent to the mobile terminal, thereby achieving the purpose of timely reminding users to replenish medications and avoiding health effects due to insufficient medications.

[0046] The control module calculates the remaining amount of the target medication based on the real-time data detected by the weight sensor. The weight sensor can sense changes in the weight of the medication within the medication placement area in real time and infer the remaining amount of the medication based on this weight change. For example, the control module uses the real-time data detected by the weight sensor, combined with the initial weight of the medication (or the known weight of an empty container), to calculate the current remaining amount of medication. The control module also calculates the remaining number of medication doses based on the remaining amount of medication and the preset single dose. For example, if the remaining amount of medication is 30 grams and the single dose is 10 grams, the remaining number of medication doses is 3. When the remaining number of medication doses falls below a preset threshold (such as 2 or 3), the control module sends a reminder to the user's mobile terminal via the wireless communication module to replenish the medication. This reminder mechanism helps users replenish medication in a timely manner, avoiding treatment interruptions due to insufficient medication. In the related art, the monitoring of the remaining amount of medicine mostly relies on manual recording or estimation by the user, which is prone to errors and leads to the inability to replenish the medicine in time when it is insufficient; this embodiment monitors the remaining amount of medicine in real time through a weight sensor, and calculates the remaining number of medications in combination with a single dose, thereby solving the problem of insufficient monitoring of the remaining amount of medicine in the related art; by monitoring the remaining amount of medicine in real time through a weight sensor, and calculating the remaining number of medications in combination with a single dose, the use of medicines can be managed more accurately, and users can check the remaining status of medicines at any time through a mobile terminal without opening the storage device for inspection. It is especially suitable for patients with chronic diseases or those with mobility difficulties. By reminding users to replenish medicines in time, it can avoid interruption of medication due to insufficient medicines, thereby reducing the health risks caused by insufficient medicines.

[0047] In an optional embodiment, the control module is also used to: record the time of each medication, the single medication dosage, the remaining number of medications and the medication collection temperature, and generate medication record information, wherein the medication time represents the time corresponding to when the control module determines that the target drug has been taken, and the medication collection temperature is used to represent the temperature data of the drug placement area corresponding to the medication time; upload the medication record information to the remote server so that the remote server can generate the corresponding drug management electronic file.

[0048] In the above embodiment, the medication time, single medication dosage, remaining medication times and medication collection temperature are recorded and medication record information is generated, which can facilitate the understanding of medication usage. The medication record information is uploaded to a remote server to generate an electronic medication management file, which can achieve long-term tracking and management of medication usage and provide users with more scientific medication guidance.

[0049] When the infrared radiation sensor and the weight sensor jointly confirm that the medicine has been taken, the control module records the current time as the medication time. The single medication dosage can be based on the preset value or user input, and the standard dosage for each medication is recorded; the remaining number of medications is the number of medications that can be supported by the remaining medicines calculated based on the real-time weight; the medication taking temperature refers to the temperature data of the medicine storage environment recorded synchronously at the time of medication, ensuring that the medicine is within the effective temperature range when it is taken; the control module uploads the above medication record information to the remote server through the wireless communication module (such as Wi-Fi / cellular network), and the remote server performs structured storage and analysis on the data to generate an electronic file of drug management, which contains key information such as medication history and temperature exposure records. By recording detailed information about each medication use (including time, dosage, remaining times and temperature), the medication use process can be managed more meticulously, providing users with comprehensive medication use records; medication record information is uploaded to a remote server to generate an electronic file, which facilitates remote management and data analysis by medical institutions or users. For example, doctors can understand patients' medication status and adjust treatment plans through electronic files; users can review their medication history through electronic files and optimize their medication habits; users do not need to manually record medication information, the device automatically completes the recording and upload, reducing the user's operating burden and improving ease of use.

[0050] In an optional embodiment, the drug storage device further includes: a fingerprint acquisition module, which is arranged on the outer cover surface of the drug storage device and is electrically connected to the control module; and an electric lock, which is controlled by the control module; wherein, when the fingerprint acquisition module recognizes a pre-stored fingerprint, the control module drives the electric lock to unlock to allow the drug storage device to be opened.

[0051] In the above embodiment, fingerprint unlocking of the drug storage device can be achieved, thereby improving the security of the drug storage device, preventing unauthorized personnel or children from accidentally opening the device, and ensuring the safe storage of target drugs.

[0052] The fingerprint acquisition module, located on the device's outer cover, collects the user's fingerprint and transmits it to the control module. The control module, which has a pre-stored database of authorized fingerprints, compares the collected fingerprint with the pre-stored fingerprints. When the control module determines that the collected fingerprint matches the pre-stored fingerprint, it sends an unlock signal to the electronic lock, which opens and allows the user to access the storage device and access medication. If the fingerprints do not match, the electronic lock remains locked, preventing unauthorized access and children from accidentally opening the device. This ensures that medications are only accessible to authorized users (such as the patient or guardian) and prevents accidental ingestion or misuse. Fingerprint recognition verifies user identity, ensuring that only authorized personnel can access medications, preventing accidental access or misuse, and improving the standardization of medication management. Fingerprint recognition is a fast and convenient verification method. Users simply place their finger on the fingerprint acquisition module to unlock the device, making operation simple and convenient, enhancing the user experience. The control module can pre-store the fingerprint information of multiple users, supporting multi-user management. Each user can unlock the device with their own fingerprint. The control module also records the user identity of each unlock for easy traceability and management. By introducing fingerprint recognition and electric lock functions, the security and management standardization of drug storage devices have been significantly improved, while taking into account the user experience. It is especially suitable for the refined management needs of multiple scenarios such as family, medical care, and elderly care.

[0053] In an optional embodiment, the drug storage device also includes: an identification module, electrically connected to the control module, for scanning the bar code or QR code or RFID tag on the target drug package when the target drug is placed in the drug placement area or taken out from the drug placement area within a preset time after the electric lock is unlocked, so as to obtain drug information and transmit it to the control module, wherein the drug information includes the type information and expiration date information of the target drug; when the control module determines that the type information of the target drug does not match the currently unlocked user or determines that the target drug has expired, the control module controls the alarm module to generate a third alarm and sends risk reminder information to the mobile terminal through the wireless communication module.

[0054] In the above embodiment, an identification module is added to scan the barcode, QR code or RFID tag on the target drug packaging to obtain the drug type and expiration date information. The control module combines the health record associated with the user's fingerprint and the system time to determine whether the drug type matches the user and whether the drug is expired. When a mismatch or expiration occurs, the alarm module is controlled to issue a third alarm and send a risk reminder message to the mobile terminal, thereby improving the safety of drug use and preventing users from accidentally taking mismatched or expired drugs.

[0055] Once the electronic lock is unlocked via fingerprint verification, the identification module activates within a preset time (e.g., 3 seconds or another duration) and automatically obtains medication information (e.g., drug name, indicated conditions) and expiration date by scanning the barcode, QR code, or RFID tag on the target medication packaging. This information is then transmitted to the control module. The control module then performs two key checks based on this collected information: First, it compares the medication information with the currently unlocked user's pre-stored medication information (e.g., prescription medications associated with the user) to determine if there is a match; and second, it compares the expiration date with the current system time to determine if the medication has expired (expiration is considered expired if the expiration date is ≤ the current time). If either of these checks is abnormal (e.g., mismatched medication or expired medication), the control module immediately controls the alarm module to issue a third alarm (a local risk alarm) and sends a risk alert to a mobile terminal via the wireless communication module (a remote warning). In the related art, even if the access personnel are restricted by fingerprint unlocking, it is still impossible to prevent authorized users from taking the wrong medicine due to negligence, such as elderly people in the family mistakenly taking their children's antihypertensive drugs, and nursing staff in nursing homes confusing the insulin of different patients. The solutions in the related art only control "who can take the medicine" but not "what medicine is taken", which makes it difficult to eliminate the risk of misuse. The solution of this embodiment blocks the possibility of "authorized users taking the wrong medicine" from a technical level through mandatory matching verification of the type of medicine and the identity of the user. In addition, the related art relies on users to manually check the expiration date of the medicine, which may lead to expired medicine being accidentally taken due to forgetfulness, poor eyesight (such as elderly users), etc., especially for medicines that require long-term refrigeration (such as biological agents), users may ignore their short expiration date, increasing the risk of medication safety. The solution of this embodiment automatically reads the expiration date information through the identification module and compares it with the current time. It can accurately identify expired drugs without manual intervention, solving the lag and error problems of manual verification. This embodiment ensures that the drugs used by authorized users strictly match their own medication needs through the chain of "fingerprint identity authentication - automatic identification of drug types - user - drug matching verification"; the identification module automatically reads the expiration date information and compares it with the current time, automatically intercepts expired drugs, and eliminates the risk of expired medication.

[0056] In an optional embodiment, the control module determines that the type information of the target drug does not match the currently unlocked user by: retrieving the pre-stored user health record associated with the fingerprint of the currently unlocked user; when the type information of the target drug is different from the drug type in the pre-stored user health record, it is determined that the type information of the target drug does not match the currently unlocked user; the control module determines that the target drug is expired by: by comparing the identified expiration date information with the current system time; when the time corresponding to the expiration date information is earlier than the current system time, it is determined that the target drug is expired.

[0057] In the above embodiment, it is possible to accurately determine whether the target drug type information matches the currently unlocked user and whether the target drug is expired. When a mismatch or expiration occurs, the alarm module can be controlled to issue a third alarm and send risk reminder information to the mobile terminal to prevent users from mistakenly taking the wrong drugs or using expired drugs, thereby ensuring medication safety.

[0058] The control module retrieves the pre-stored user health profile associated with the fingerprint of the currently unlocked user. The health profile contains information about the types of medications permitted for the user. Once the identification module obtains the target medication type information, the control module compares it with the medication types in the health profile. If the target medication type information does not match the medication type in the health profile, the control module determines that the medication does not match the currently unlocked user. The unique association mechanism between fingerprints and health profiles (e.g., "Fingerprint A → User A's Diabetes Medication Profile") ensures that each user can only access medications explicitly permitted in the profile, further eliminating the risk of an authorized user accessing the wrong medication. The control module obtains the expiration date information of the target medication identified by the identification module and compares it with the current system time. If the expiration date corresponds to a time earlier than the current system time, the control module determines that the medication has expired. This embodiment, through the association of user health profiles, enables personalized medication management, ensuring that each user can only use medications that comply with their health profile, further enhancing the scientific and standardized nature of medication management. Users do not need to manually check the medication type and expiration date; the device automatically verifies and alerts the user, reducing the user's operational burden and improving user convenience.

[0059] In an optional embodiment, the drug storage device also includes: a lithium battery for powering the temperature monitoring module, the control module, the alarm module and the wireless communication module; a low-battery detection unit electrically connected to the lithium battery and the control module, for detecting the battery level of the lithium battery and transmitting it to the control module. When the control module determines that the battery level of the lithium battery is lower than a preset battery threshold, the control module sends a charging reminder message to the mobile terminal through the wireless communication module.

[0060] In the above embodiment, the lithium battery powers the temperature monitoring module, the control module, the alarm module and the wireless communication module to ensure the normal operation of the device; the low-battery detection unit detects the battery level of the lithium battery. When the battery level is lower than the preset battery level threshold, the control module sends a charging reminder message to the mobile terminal through the wireless communication module to avoid affecting the device function due to insufficient battery level.

[0061] A rechargeable lithium battery is used as the main power source to enhance the device's mobility and flexibility, providing a stable working power source for the temperature monitoring module, control module, alarm module, and wireless communication module. The low-battery detection unit monitors the remaining power of the lithium battery in real time. When the power level is detected to be lower than a preset threshold (e.g., 20%), a low-battery signal is sent to the control module. The control module sends a charging reminder message to the user's mobile terminal via the wireless communication module, reminding the user to charge in time to ensure the normal operation of the device. This embodiment uses the low-battery detection unit to monitor the power level of the lithium battery in real time and reminds the user to charge when the power level is low, ensuring that the device can continue to operate normally and avoiding device failure or data loss due to low power. At the same time, the user does not need to frequently check the power level of the device. The device will automatically remind the user to charge, reducing the user's operational burden. It is especially suitable for elderly users, busy office workers, and other groups. By actively warning to avoid functional failure due to low power, the user's trust in the reliability of the device is enhanced, ensuring that the user can rely on the device for medication management with confidence, and improving the convenience of use. In actual applications, lithium batteries can support low-power mode operation (such as reducing the frequency of temperature monitoring during non-working hours). Combined with power warnings, users can reasonably arrange charging cycles based on reminders, balance battery life and functional response speed, and adapt to the usage frequency of different users (such as high-frequency daily medication collection and low-frequency weekly medication collection scenarios).

[0062] In an optional embodiment, the alarm module includes: an audible and visual alarm component integrated into the storage container shell, the audible and visual alarm component including an LED indicator light and a buzzer; when the temperature data is greater than or equal to the preset failure temperature critical value and less than the preset dangerous temperature threshold, a first-level alarm is triggered; when the temperature data is greater than or equal to the preset dangerous temperature threshold, a second-level alarm is triggered, wherein the first alarm includes a first-level alarm and a second-level alarm.

[0063] In the above embodiment, the sound and light alarm component is integrated into the storage container shell, and an alarm can be issued through the LED indicator and the buzzer when the temperature is abnormal, which can remind the user intuitively and promptly; based on the comparison of temperature data with the preset failure temperature critical value and the preset dangerous temperature threshold, different levels of alarms are triggered, allowing the user to understand the severity of the temperature abnormality more clearly and take timely measures to ensure the effectiveness and safety of the drug.

[0064] The alarm module is integrated into the sound and light alarm component of the storage container shell, specifically including an LED indicator light (visual reminder) and a buzzer (auditory reminder), realizing local alarm through the dual methods of "visual + auditory"; the control module compares the temperature data obtained by the temperature monitoring module with two preset thresholds: when the preset failure temperature critical value ≤ temperature data < preset dangerous temperature threshold, a level one alarm is triggered (such as LED light flashing yellow + buzzer beeps intermittently at a low frequency); when the temperature data ≥ the preset dangerous temperature threshold, a level two alarm is triggered (such as LED light constantly on red + buzzer beeps continuously at a high frequency); the level one alarm and the level two alarm together constitute the aforementioned first alarm, corresponding to temperature anomalies of different severity. This embodiment uses a graded alarm mechanism to issue different levels of alarm signals according to the severity of the temperature anomaly, helping users quickly determine the severity of the temperature anomaly and take timely measures; the sound and light alarm component (LED indicator and buzzer) reminds users through dual visual and auditory signals, ensuring that the alarm signal is more obvious and reducing the possibility of users ignoring the alarm; through timely and obvious alarm signals, it is ensured that users can take timely measures when an abnormality occurs in the drug storage environment, avoiding the loss of drug effectiveness due to excessive temperature, and ensuring the safety and effectiveness of the drug; the graded alarm mechanism further enhances the intelligence level of the drug storage device, enabling it to make more accurate responses according to different temperature anomalies.

[0065] In an optional embodiment, the drug storage device further includes: a display module electrically connected to the control module, the display module being configured to display temperature data of the target drug and a status indicating whether the drug has been taken.

[0066] In the above embodiment, the temperature data of the target drug can be displayed in real time, allowing the user to timely understand the temperature of the drug storage environment. It can also display the status of whether the target drug has been taken, so that the user can clearly understand the drug taking status.

[0067] This embodiment realizes the visualization of key information of drug storage through the display module. Specifically, the display module is electrically connected to the control module. The control module transmits the real-time temperature data collected by the temperature monitoring module and the drug access status (used / not taken) determined by the weight sensor and the infrared radiation sensor to the display module. The display module displays this information to the user in an intuitive form (such as numbers, icons, and text), so that the user can directly obtain the current storage temperature and access status of the drug through the local interface of the device.

[0068] In an optional embodiment, the drug storage device also includes: a voice broadcast module, which is electrically connected to the control module. When the target drug is taken, the display module is also used to display the medication standards corresponding to the target drug, and the voice broadcast module is used to broadcast the medication standards.

[0069] In the above embodiment, when the target drug is taken, the display module displays the medication standard, and the voice broadcast module broadcasts the medication standard, which can help the user intuitively obtain the medication standard and facilitate the user to use the drug correctly.

[0070] The voice broadcast module is electrically connected to the control module and is used to convert text information (such as medication standards) into voice and broadcast it to the user. The voice broadcast module can use built-in voice synthesis technology to convert the medication standard information transmitted by the control module into a voice signal output; when the target drug is taken, the display module not only displays the temperature data and access status of the drug, but also displays the medication standards corresponding to the target drug. These medication standards may include medication dosage, medication method, medication precautions and other information; when the control module detects that the target drug is taken, it triggers the display module to display the medication standards, and at the same time controls the voice broadcast module to broadcast this information. This dual prompt method (visual and auditory) can ensure that the user can understand the correct medication method in a timely manner when taking the drug, which is especially suitable for the elderly; the addition of the voice broadcast module further improves the intelligence level of the drug storage device, enabling it to better serve users and provide more comprehensive information support.

[0071] In an optional embodiment, the drug storage device also includes: a cooling plate, which is attached to the inner wall of the storage container and is used to reduce the temperature of the drug placement area; a power adjustment module, which is electrically connected to the control module and the cooling plate; wherein the control module dynamically adjusts the power of the cooling plate according to the difference between the temperature data obtained in real time by the temperature monitoring module and the preset failure temperature critical value: when the temperature data is greater than or equal to the preset failure temperature critical value, the power of the cooling plate is gradually increased until the temperature of the drug placement area is lower than the preset failure temperature critical value.

[0072] In the above embodiment, the cooling plate can lower the temperature of the drug placement area. The power adjustment module cooperates with the control module to dynamically adjust the cooling plate power according to the difference between the temperature data and the preset failure temperature critical value. When the temperature data is greater than or equal to the preset failure temperature critical value, the cooling plate power is gradually increased until the temperature of the drug placement area is less than the preset failure temperature critical value. The temperature of the drug placement area can be maintained in an appropriate range to ensure the effectiveness and safety of the target drug.

[0073] The cooling plate is attached to the inner wall of the storage container and uses the cooling effect to reduce the temperature of the drug placement area. The cooling plate is typically made of semiconductor material and uses the Peltier effect to transfer heat, thereby achieving cooling. A power regulation module is electrically connected to the control module and the cooling plate to control the operating power of the cooling plate. The power regulation module dynamically adjusts the cooling plate power according to the control module's instructions to achieve precise temperature control. The control module dynamically adjusts the cooling plate power based on the difference between the real-time temperature data obtained by the temperature monitoring module and the preset failure temperature threshold. When the temperature data is greater than or equal to the preset failure temperature threshold, the control module gradually increases the cooling plate power until the temperature of the drug placement area is below the preset failure temperature threshold. This dynamic adjustment mechanism ensures that the temperature of the drug storage environment remains within a safe range. Optionally, the user can send instructions to the drug storage device via a mobile terminal to actively adjust the cooling plate power to achieve cooling. By dynamically adjusting the power of the refrigeration plate, the temperature of the drug storage environment is ensured to always remain within the preset safety range, avoiding drug ineffectiveness due to temperature fluctuations; users do not need to manually adjust the refrigeration settings, the device can automatically adjust according to real-time temperature data, or the temperature can be adjusted by remote commands from a mobile terminal, reducing the user's operating burden, improving ease of use, and further enhancing the intelligence level of the drug storage device, enabling it to better serve users and provide more precise temperature control.

[0074] The present application also provides an intelligent reminder method, which is applied to the drug storage device of any of the aforementioned embodiments. Figure 2 This is a flow chart of an intelligent reminder method provided by an embodiment of the present application, which includes: Step S201: The temperature monitoring module monitors the temperature data of the drug placement area in real time, wherein the drug placement area is used to store the target drug; Step S202: The control module receives temperature data and compares the temperature data with a preset failure temperature threshold to determine whether the temperature data is abnormal. Step S203, when it is determined that the temperature data is greater than or equal to the preset failure temperature critical value, and when it is determined that there is an abnormality in the temperature data, the control module controls the alarm module to issue a first alarm, and sends the temperature abnormality information to the mobile terminal through the wireless communication module; and when there is no abnormality in the temperature data and when the target drug is not taken within the set time, the control module controls the alarm module to issue a second alarm, and sends medication reminder information to the mobile terminal through the wireless communication module.

[0075] Through the above steps, the temperature data of the drug placement area can be monitored in real time, temperature anomalies can be detected in time, and alarms and notifications can be issued to mobile terminals to prevent drugs from becoming ineffective due to temperature anomalies. It can also remind users to take medication if the target medication is not taken on time, thereby improving the timeliness and standardization of medication.

[0076] The drug placement area is used to store target drugs, and the temperature data directly reflects the status of the drug storage environment. The temperature monitoring module monitors the temperature data of the drug placement area in real time and transmits this data to the control module; the control module receives the temperature data and compares it with the preset failure temperature critical value. If the temperature data is greater than or equal to the preset failure temperature critical value, the control module determines that the temperature data is abnormal. If the temperature data is lower than the preset failure temperature critical value, the control module determines that the temperature data is normal; when the temperature data is abnormal, the control module controls the alarm module to issue a first alarm and send the temperature abnormality information to the user's mobile terminal through the wireless communication module; when the temperature data is normal, but the target drug is not taken within the set time, the control module controls the alarm module to issue a second alarm and send a medication reminder message to the mobile terminal through the wireless communication module. It solves the problem that drug storage devices in related technologies usually lack real-time temperature monitoring functions and cannot detect temperature abnormalities in time, which may cause the drugs to become ineffective without being aware of them, and the problem that the medication reminder function is usually relatively simple, cannot be associated with the drug storage environment, and is easily ignored by users; by real-time monitoring of temperature data and timely alarms, it ensures that the drugs are always in a suitable storage environment, avoids drug failure due to temperature abnormalities, and ensures the safety and effectiveness of the drugs; users do not need to manually check the drug storage environment and medication time, the device can automatically monitor and remind users in time, reducing the user's operating burden and improving usage convenience and satisfaction; through real-time monitoring, intelligent judgment and information transmission functions, the intelligence level of the drug storage device is further improved, enabling it to better serve users and provide more comprehensive support. Figure 3 This is a schematic diagram of an application scenario provided by an embodiment of the present application, which monitors the target drug through a drug storage device and sends corresponding information to the mobile terminal for reminder when conditions are met, such as abnormal temperature information and medication reminder messages.

[0077] Optionally, the above method further includes: the control module receiving the set time of medication, single medication dosage and reminder method set by the mobile terminal through the wireless communication module.

[0078] As an optional embodiment, the drug storage device further includes a weight sensor and an infrared radiation sensor, both electrically connected to the control module. The weight sensor is located at the bottom of the drug storage area to monitor the weight of the target drug in real time, and the infrared radiation sensor is located inside the access opening of the drug storage area to detect whether there is an occlusion signal indicating an object passing through the access opening. The control module determines the access status of the target drug in the following manner: when the infrared radiation sensor detects an occlusion signal and the weight sensor detects a decrease in weight, it is comprehensively determined that the target drug has been accessed. If only the infrared radiation sensor detects an occlusion signal or only the weight sensor detects a decrease in weight, it is not determined to be valid access.

[0079] As an optional implementation, the control module records the time of each medication, the single medication dosage, the remaining number of medications and the medication collection temperature, and generates medication record information, wherein the medication time represents the time corresponding to when the control module determines that the target drug has been taken, and the medication collection temperature is used to represent the temperature data of the drug placement area corresponding to the medication time; the medication record information is uploaded to the remote server so that the remote server can generate the corresponding drug management electronic file.

[0080] The device and method embodiments provided in the above embodiments belong to the same concept. Their specific implementation is detailed in the device embodiment and will not be repeated here. In addition, in the above embodiments, the description of each embodiment has its own focus. For parts not detailed in one embodiment, please refer to the relevant description of other embodiments.

[0081] Through the description of the above embodiments, those skilled in the art can clearly understand that the methods according to the above embodiments can be implemented by means of software plus the necessary general hardware platform. Of course, they can also be implemented by hardware, but in many cases the former is a better implementation method. Based on this understanding, the technical solution of the present application, or the part that contributes to the existing technology, can be embodied in the form of a software product. The computer software product is stored in a storage medium (such as ROM / RAM, magnetic disk, optical disk), and includes a number of instructions for enabling a terminal device (which can be a mobile phone, computer, server, or network device, etc.) to execute the methods described in each embodiment of the present application.

[0082] The present application also provides a computer-readable storage medium, which stores instructions. When the instructions are executed, any one of the above-mentioned method steps is executed.

[0083] In an exemplary embodiment, the computer-readable storage medium may include, but is not limited to, various media that can store computer programs, such as a USB flash drive, a read-only memory (ROM), a random access memory (RAM), a mobile hard disk, a magnetic disk, or an optical disk.

[0084] This application also discloses an electronic device. Figure 4 As shown, Figure 4 4 is a schematic diagram of the structure of an electronic device provided by an embodiment of the present application. The electronic device 400 may include: at least one processor 401, at least one communication bus 402, a user interface 403, at least one network interface 404, and a memory 405.

[0085] The communication bus 402 is used to implement the connection and communication between these components.

[0086] The user interface 403 may include a display screen (Display) and a camera (Camera). Optionally, the user interface 403 may also include a standard wired interface and a wireless interface.

[0087] The network interface 404 may optionally include a standard wired interface or a wireless interface (such as a WI-FI interface).

[0088] Processor 401 may include one or more processing cores. Processor 401 utilizes various interfaces and circuits to connect various components within the electronic device (e.g., a server). It executes instructions, programs, code sets, or instruction sets stored in memory 405, and accesses data stored in memory 405 to perform various server functions and process data. Optionally, processor 401 may be implemented using at least one of the following hardware forms: a digital signal processing (DSP), a field-programmable gate array (FPGA), or a programmable logic array (PLA). Processor 401 may integrate one or a combination of a central processing unit (CPU), a graphics processing unit (GPU), and a modem. The CPU primarily processes the operating system, user interface, and application programs; the GPU is responsible for rendering and drawing content displayed on the display; and the modem handles wireless communications. It is understood that the modem may also be implemented as a separate chip, rather than integrated into processor 401.

[0089] Among them, the memory 405 may include a random access memory (RAM) or a read-only memory (Read-Only Memory). Optionally, the memory 405 includes a non-transitory computer-readable storage medium. The memory 405 can be used to store instructions, programs, codes, code sets or instruction sets. The memory 405 may include a program storage area and a data storage area, wherein the program storage area may store instructions for implementing an operating system, instructions for at least one function (such as a touch function, a sound playback function, an image playback function, etc.), instructions for implementing the above-mentioned various method embodiments, etc.; the data storage area may store data involved in the above-mentioned various method embodiments, etc. The memory 405 may also optionally be at least one storage device located away from the aforementioned processor 401. Refer to Figure 4 , the memory 405 as a computer storage medium may include an operating system, a network communication module, a user interface module and an application program of an intelligent reminder method.

[0090] exist Figure 4 In the electronic device 400 shown, the user interface 403 is mainly used to provide an input interface for the user and obtain the data input by the user; and the processor 401 can be used to call an application of an intelligent reminder method stored in the memory 405. When executed by one or more processors 401, the electronic device 400 executes one or more of the methods described in the above embodiments. It should be noted that for the aforementioned method embodiments, for the sake of simplicity of description, they are all expressed as a series of action combinations, but those skilled in the art should know that this application is not limited to the described order of actions, because according to this application, certain steps can be performed in other orders or simultaneously. Secondly, those skilled in the art should also know that the embodiments described in the specification are all preferred embodiments, and the actions and modules involved are not necessarily required for this application.

[0091] In the above embodiments, the description of each embodiment has its own focus. For parts that are not described in detail in a certain embodiment, reference can be made to the relevant descriptions of other embodiments.

[0092] The foregoing is merely an exemplary embodiment of the present disclosure and is not intended to limit the scope of the present disclosure. In other words, any equivalent variations and modifications made in accordance with the teachings of the present disclosure are still within the scope of the present disclosure. Those skilled in the art will readily conceive of other embodiments of the present disclosure after considering the disclosure herein.

[0093] This application is intended to cover any modifications, uses or adaptations of the present disclosure that follow the general principles of the present disclosure and include common knowledge or customary technical means in the technical field not described in the present disclosure.

Claims

1. A drug storage device, characterized in that: include: A storage container having a drug placement area therein for storing the target drug; A temperature monitoring module, fixed to the inner wall of the storage container, for obtaining temperature data of the drug placement area in real time; a control module, electrically connected to the temperature monitoring module, for acquiring the temperature data and determining whether the temperature data is abnormal; an alarm module, electrically connected to the control module, and configured to receive an alarm instruction sent by the control module and issue a first alarm when the control module determines that the temperature data is abnormal; a wireless communication module, electrically connected to the control module, and configured to send temperature anomaly information to a mobile terminal; The control module compares the temperature data with a preset failure temperature threshold, and when it is determined that the temperature data is greater than or equal to the preset failure temperature threshold, determines that the temperature data is abnormal, and controls the alarm module to issue the first alarm; The control module is further configured to control the alarm module to issue a second alarm and send medication reminder information to the mobile terminal via the wireless communication module when there is no abnormality in the temperature data and the target medicine is not taken within the set time.

2. The drug storage device according to claim 1, characterized in that The drug storage device further comprises: A weight sensor, electrically connected to the control module, disposed at the bottom of the drug placement area, for monitoring the weight of the target drug in real time; An infrared radiation sensor, electrically connected to the control module, is disposed inside the access opening of the medicine placement area and is used to detect whether an object passes through the access opening, generating an occlusion signal; The control module determines the use status of the target drug in the following manner: When the infrared radiation sensor detects a shielding signal and the weight sensor detects a decrease in the weight value, it is comprehensively determined that the target medicine has been taken.

3. The drug storage device according to claim 2, characterized in that The control module is further configured to: determining the remaining amount of the target drug according to the real-time detection value of the weight sensor; Calculating the remaining number of medication doses based on the remaining amount and a preset single medication dose; When the remaining number of medication times is lower than a preset number threshold, a reminder message for replenishing medication is sent to the mobile terminal through the wireless communication module.

4. The drug storage device according to claim 2, characterized in that The control module is further configured to: Recording each medication time, single medication dosage, remaining medication times, and medication removal temperature, and generating medication record information, wherein the medication time represents the time corresponding to when the control module determines that the target medication has been taken, and the medication removal temperature is used to represent the temperature data of the medication placement area corresponding to the medication time; The medication record information is uploaded to a remote server so that the remote server can generate a corresponding medication management electronic file.

5. The drug storage device according to claim 1, characterized in that The drug storage device further comprises: a fingerprint collection module, disposed on the outer cover surface of the drug storage device and electrically connected to the control module; an electric lock, controlled by the control module; Wherein, when the fingerprint collection module recognizes the pre-stored fingerprint, the control module drives the electric lock to unlock to allow the drug storage device to be opened.

6. The drug storage device according to claim 5, characterized in that The drug storage device further comprises: an identification module electrically connected to the control module, configured to scan a barcode, a QR code, or an RFID tag on the target drug package when the target drug is placed in or taken out of the drug placement area within a preset time period after the electric lock is unlocked, to obtain drug information and transmit the information to the control module, wherein the drug information includes type information and expiration date information of the target drug; When the control module determines that the type information of the target drug does not match the currently unlocked user or determines that the target drug has expired, the control module controls the alarm module to generate a third alarm and sends risk reminder information to the mobile terminal through the wireless communication module.

7. The drug storage device according to claim 6, characterized in that The control module determines that the type information of the target drug does not match the currently unlocked user by: retrieving a pre-stored user health file associated with the fingerprint of the currently unlocked user; when the type information of the target drug is different from the drug type in the pre-stored user health file, determining that the type information of the target drug does not match the currently unlocked user; The control module determines that the target drug has expired by comparing the identified expiration date information with the current system time; when the time corresponding to the expiration date information is earlier than the current system time, determining that the target drug has expired.

8. The drug storage device according to claim 1, wherein: The drug storage device further comprises: A lithium battery, used to power the temperature monitoring module, the control module, the alarm module and the wireless communication module; A low battery detection unit is electrically connected to the lithium battery and the control module, and is used to detect the battery level of the lithium battery and transmit it to the control module. When the control module determines that the battery level of the lithium battery is lower than a preset battery level threshold, it sends a charging reminder message to the mobile terminal through the wireless communication module.

9. The drug storage device according to claim 1, wherein: The alarm module includes: an audible and visual alarm component integrated into the storage container housing, the audible and visual alarm component including an LED indicator light and a buzzer; When the temperature data is greater than or equal to the preset failure temperature critical value and less than the preset dangerous temperature threshold, a first-level alarm is triggered; when the temperature data is greater than or equal to the preset dangerous temperature threshold, a second-level alarm is triggered, wherein the first alarm includes the first-level alarm and the second-level alarm.

10. An intelligent reminder method, characterized in that: The drug storage device according to any one of claims 1 to 9 comprises: The temperature monitoring module monitors the temperature data of the drug placement area in real time, wherein the drug placement area is used to store the target drug; The control module receives the temperature data and determines whether the temperature data is abnormal by comparing the temperature data with a preset failure temperature threshold; When it is determined that the temperature data is greater than or equal to the preset failure temperature critical value, and when it is determined that the temperature data is abnormal, the control module controls the alarm module to issue a first alarm, and sends the temperature abnormality information to the mobile terminal through the wireless communication module; and, when there is no abnormality in the temperature data and when the target drug is not taken within the set time, the control module controls the alarm module to issue a second alarm, and sends medication reminder information to the mobile terminal through the wireless communication module.